Vitamin K2 therapy for a patient with myelodysplastic syndrome.
Yaguchi
M
M
Miyazawa
K
K
Otawa
M
M
Ito
Y
Y
Kawanishi
Y
Y
Toyama
K
K
D000284:Administration, Oral; D000368:Aged; D004900:Erythroblasts; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000188:drug therapy*; D014812:Vitamin K / Q000008:administration & dosage / Q000627:therapeutic use*
D006490:Hemostatics; D014812:Vitamin K